CANCER GENETICS AND EPIGENETICS
癌症遗传学和表观遗传学
基本信息
- 批准号:7944873
- 负责人:
- 金额:$ 7.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-07 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAllelic ImbalanceAntineoplastic AgentsArchitectureAreaBasic ScienceBehavioralBiochemicalBiological MarkersBiological ModelsCancer Center Support GrantChromatinChromosomal InstabilityChromosome abnormalityCollaborationsComputer SimulationDNADNA DamageDNA Modification ProcessDNA RepairDevelopmentEpigenetic ProcessEventFundingGene ExpressionGene MutationGeneticGenomeGenomic InstabilityHumanInstitutesInvestigationMaintenanceMalignant NeoplasmsMolecularMutagenesisNuclearNucleic AcidsPublicationsPublishingSuppressor GenesTumor Suppressor Genesantitumor agentcancer cellcancer diagnosiscancer geneticschromatin modificationchromatin remodelingcollegedrug developmentfunctional genomicsgenetic variantmedical schoolsmembernoveloutcome forecastprogramsresponsetumortumorigenesis
项目摘要
Program 1. Cancer Genetics and Epigenetics (CGE): DNA damage, genetic mutations, genomic
instability and alterations in DNA/chromatin modifications that modify gene expression are all critical events
that contribute to the development of cancers in humans. The primary themes of the CGE Program reflect a
major emphasis on basic science investigations directly related to oncogenesis. The CGE Program's four
main thematic areas are: (1) DNA damage, repair, mutagenesis and genetic instability; (2) epigenetics,
including DNA and chromatin modification and chromatin remodeling; (3) chromosome instability and nuclear
architecture; (4) cancer genetics and functional genomics. The aims of the CGE Program are: (1) To
elucidate the underlying molecular and biochemical mechanisms that result in the establishment and
maintenance of genetic instability during tumor development and progression. (2) To elucidate and
understand how epigenetic modifications of DNA and chromatin structural components impact gene
expression programs and other nucleic acid transactions during tumorigenesis. (3) To understand the
mechanisms underlying chromosomal aberrations, allelic imbalances and alterations in nuclear architecture
and their contributions to multi-step tumorigenesis. (4) To identify and characterize novel oncogenes and
tumor suppressor genes and to develop genome-scale discovery and analysis platforms and computational
models to identify genetic loci and genetic variants involved in tumorigenesis. The CGE Program is
comprised of 26 members from 10 departments within the School of Medicine and Emory College.
Currently, there are 24 funded program members with total support of approximately $9 million per year, of
which NCI funding represents $3.9M ($2.6M direct). From 2003-2008 the CGE program members published
400 articles. Of these total publications, 39 (9.75%) are intraprogrammatic collaborations and 82 (20.5%) are
interprogrammatic collaborations. From 2006-2008, CGE members published 183 articles.
Intraprogrammatic collaborations account for 21 (11.5 %) and interprogrammatic collaborations account for
39 (21.3 %) of these publications.
计划1.癌症遗传学和表观遗传学(CGE):DNA损伤、基因突变、基因组
改变基因表达的DNA/染色质修饰的不稳定性和改变都是关键事件
这会导致人类癌症的发展。专家咨询小组方案的主要主题反映了
主要强调与肿瘤发生直接相关的基础科学研究。CGE计划的四个
主要主题领域是:(1)DNA损伤、修复、突变和遗传不稳定;(2)表观遗传学,
包括DNA和染色质修饰和染色质重塑;(3)染色体不稳定和核
(4)癌症遗传学和功能基因组学。CGE方案的目标是:(1)
阐明导致疾病发生和发展的潜在分子和生化机制
在肿瘤发生和发展过程中维持遗传不稳定性。(2)澄清及
了解DNA和染色质结构成分的表观遗传修饰如何影响基因
在肿瘤发生过程中的表达程序和其他核酸交易。(3)了解
染色体异常、等位基因失衡和核结构改变的机制
以及它们在多步骤肿瘤发生中的作用。(4)鉴定和鉴定新的癌基因和
肿瘤抑制基因和开发基因组规模的发现和分析平台和计算
识别与肿瘤发生有关的遗传基因和遗传变异的模型。CGE计划是
由来自医学院和埃默里学院10个系的26名成员组成。
目前,有24个受资助的方案成员,每年的总支助约为900万美元,其中
其中NCI的资金为390万美元(直接资金为260万美元)。2003-2008年间,CGE项目成员发表了
400篇文章。在这些出版物中,39份(9.75%)是计划内合作,82份(20.5%)是计划内合作
程序间的协作。2006-2008年间,专家咨询小组成员发表了183篇论文。
计划内协作占21(11.5%),计划间协作占
其中39篇(21.3%)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul William Doetsch其他文献
Paul William Doetsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul William Doetsch', 18)}}的其他基金
Project 2: Oxidative DNA Damage and Genetic Instability In Models Of Intestinal
项目2:肠道模型中的氧化DNA损伤和遗传不稳定性
- 批准号:
8099687 - 财政年份:2010
- 资助金额:
$ 7.98万 - 项目类别:
Project 2: Oxidative DNA Damage and Genetic Instability In Models Of Intestinal
项目2:肠道模型中的氧化DNA损伤和遗传不稳定性
- 批准号:
7511051 - 财政年份:2008
- 资助金额:
$ 7.98万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7194447 - 财政年份:2007
- 资助金额:
$ 7.98万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
8107849 - 财政年份:2007
- 资助金额:
$ 7.98万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7492119 - 财政年份:2007
- 资助金额:
$ 7.98万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7667814 - 财政年份:2007
- 资助金额:
$ 7.98万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7879358 - 财政年份:2007
- 资助金额:
$ 7.98万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.98万 - 项目类别:
Research Grant














{{item.name}}会员




